GlassScriptPhysician profile
Maria Vasquez
NPI 1447606124
$1,367.30
in general payments reported to CMS, 2019-2025
9 companies · $97.60 in 2025
The $97.60 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,139 · 2023: $49.31 · 2024: $81.42 · 2025: $97.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,138.97 | 2022 | |
| Astellas Pharma US INC | $55.89 | 2024-2025 | Veozah |
| Seqirus USA INC | $48.80 | 2024 | |
| Organon LLC | $35.00 | 2023 | Nexplanon |
| Hologic Sales and Service, LLC | $28.00 | 2025 | Aptima |
| Mayne Pharma Commercial LLC | $16.58 | 2025 | |
| Exeltis, USA INC. | $16.14 | 2025 | Slynd |
| Cumberland Pharmaceuticals, INC. | $14.31 | 2023 | Kristalose |
| Sumitomo Pharma America, INC. | $13.61 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.